All lobbying filings
NVG, LLC
Lobbying for ACCENDRA HEALTH INC. · Global healthcare solutions company.
Filing · LD-2 quarterly report
Q3 termination
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Virginia
Representation ended
Sep 30, 2026
The registrant reported terminating its work for this client.
Government bodies contacted
2
Lobbying activity
1
Issues related to electronic prescribing, including clinical data element template for Durable Medical Equipment. Issues related to Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Updates and DMEPOS accreditation requirements in DMEPOS Calendar Year 2026 Final Rule. H.R.2902/S.1406 - Supplemental Oxygen Access Reform (SOAR) Act of 2025. S.4037 - Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act.